This week, we’re reading about the 340B program, the dismissal of a nationwide class action lawsuit against CVS and other PBMs, PBM reforms in several states, and many other topics.
- Politico: FDA rolls out new rare-disease drug playbook
- KFF: TrumpRx: What’s the Value for Customers?
- Healthcare Brew: Why drugmakers and hospitals are fighting over the 340B program
- Healthcare Brew: What new PBM reforms mean for pharma
- Drug Topics: Community Pharmacy Lifestyle Program Could Improve Prediabetes Risk Factors
- Legal Newsline: Judge dismisses antitrust class against CVS, major PBMs
- Insurance Business: Arkansas Insurance Department updates "gold card" appeals for healthcare providers
- The Connection: CVS says bill will force closure of 134 pharmacies in Tennessee. Lawmaker calls it ‘fear-mongering.’
- NC Health News: PBM reforms promise relief for NC’s independent pharmacies
- The Journal Gazette: Medical spas, compounded drugs in focus as Indiana lawmakers hear warnings, pushback
- Hays Post: Kansas Senate plunges ahead with bipartisan bill targeting prescription drug middlemen
- Centre Daily Times: Republican state senators propose pharmacy benefit manager reform; Democratic House member advances his plan
- Patch: Chicago State Rally Renews Call to Protect 340B Drug Program as Legislative Pressure Builds
- Hoodline: Dollar Stores Swarm Empty Sacramento Pharmacies, Leaving Health Gaps Behind
- VermontBiz: $1.4 million in federal funding to help build pharmacies in Caledonia County
- 11 News: Aspinwall pharmacy owner to push for industry changes at State of the Union address
NCPA
